Search Results

There are 9384 results for: content related to: Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity

  1. Achievements, challenges and unmet needs for haemophilia patients with inhibitors

    Haemophilia

    Volume 22, Issue S1, January 2016, Pages: 1–24, Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer, M. Soucie, S. Claeyssens, D.w. Scott, R. d'Oiron, G. Lavigne-Lissalde, G. Kenet, C. Escuriola Ettingshausen, A. Borel-Derlon, T. Lambert, G. Pasta and C. Négrier

    Version of Record online : 5 JAN 2016, DOI: 10.1111/hae.12860

  2. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates

    Haemophilia

    Volume 10, Issue 5, September 2004, Pages: 459–469, Y. Lin, X. Yang, M.-C. Chevrier, S. Craven, T. W. Barrowcliffe, R. Lemieux and F. A. Ofosu

    Version of Record online : 12 AUG 2004, DOI: 10.1111/j.1365-2516.2004.00957.x

  3. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements

    Haemophilia

    Volume 20, Issue 4, July 2014, Pages: 550–558, M. Trossaert, A. Lienhart, C. Nougier, M. Fretigny, M. Sigaud, S. Meunier, M. Fouassier, C. Ternisien, C. Negrier and Y. Dargaud

    Version of Record online : 12 FEB 2014, DOI: 10.1111/hae.12381

  4. Activation, activity and inactivation of factor VIII in factor VIII products

    Haemophilia

    Volume 22, Issue 3, May 2016, Pages: 462–473, T. Orfeo, R. Elsman, M. Gissel, K. G. Mann and S. Butenas

    Version of Record online : 29 JAN 2016, DOI: 10.1111/hae.12872

  5. You have free access to this content
    Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 2–16, P. M. Mannucci, Q. Shi, S. Bonanad and R. Klamroth

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12465

    Corrected by:

    Erratum: Erratum

    Vol. 20, Issue 5, e376, Version of Record online: 28 AUG 2014

  6. You have free access to this content
    Heme binds to factor VIII and inhibits its interaction with activated factor IX

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 6, June 2012, Pages: 1062–1071, Y. REPESSÉ, J. D. DIMITROV, I. PEYRON, E. FARROKHI MOSHAI, L. KIGER, S. DASGUPTA, S. DELIGNAT, M. C. MARDEN, S. V. KAVERI and S. LACROIX-DESMAZES

    Version of Record online : 31 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04724.x

  7. Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

    Haemophilia

    Volume 21, Issue 3, May 2015, Pages: 343–350, S. Kepa, B. Horvath, S. Reitter-Pfoertner, M. Schemper, P. Quehenberger, M. Grundbichler, M. Heistinger, P. Neumeister, C. Mannhalter and I. Pabinger

    Version of Record online : 13 JAN 2015, DOI: 10.1111/hae.12592

  8. You have free access to this content
    New predictive approaches for ITI treatment

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 27–43, G. D. Minno, E. Santagostino, K. Pratt and C. Königs

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12467

  9. The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro

    Haemophilia

    Volume 18, Issue 6, November 2012, Pages: 917–925, F. A. Ofosu, H. Tse, A. Naqvi, H. Bhakta and Y. Song

    Version of Record online : 3 JUN 2012, DOI: 10.1111/j.1365-2516.2012.02861.x

  10. You have free access to this content
    A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate®P/ Humate®-P: History and clinical performance

    European Journal of Haematology

    Volume 80, Issue s70, May 2008, Pages: 3–35, Erik Berntorp, William Archey, Günter Auerswald, Augusto B. Federici, Massimo Franchini, Sigurd Knaub, Wolfhart Kreuz, Stefan Lethagen, Pier M. Mannucci, Hartmut Pollmann, Inge Scharrer and Keith Hoots

    Version of Record online : 1 APR 2008, DOI: 10.1111/j.1600-0609.2008.01049.x

  11. Characterization of five associations of F8 missense mutations containing FVIII B domain mutations

    Haemophilia

    Volume 22, Issue 4, July 2016, Pages: 583–589, Y. Jourdy, C. Nougier, O. Roualdes, M. Fretigny, B. Durand, C. Negrier and C. Vinciguerra

    Version of Record online : 25 FEB 2016, DOI: 10.1111/hae.12906

  12. You have free access to this content
    Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain

    Journal of Thrombosis and Haemostasis

    Volume 4, Issue 10, October 2006, Pages: 2172–2179, F. E. RAWLE, K. P. PRATT, A. LABELLE, H. L. WEINER, C. HOUGH and D. LILLICRAP

    Version of Record online : 5 JUL 2006, DOI: 10.1111/j.1538-7836.2006.02118.x

  13. You have full text access to this OnlineOpen article
    Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: 905–911, M. I. Bravo, B. Da Rocha-Souto, S. Grancha and J. I. Jorquera

    Version of Record online : 25 AUG 2014, DOI: 10.1111/hae.12494

  14. Predictive immunogenicity of Refacto®AF

    Haemophilia

    Volume 20, Issue 4, July 2014, Pages: 486–492, S. Delignat, Y. Repessé, L. Gilardin, J. D. Dimitrov, Y.C. Lone, S. V. Kaveri and S. Lacroix-Desmazes

    Version of Record online : 30 DEC 2013, DOI: 10.1111/hae.12348

  15. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

    Haemophilia

    Volume 23, Issue 2, March 2017, Pages: 292–299, J. Kahle, A. Orlowski, D. Stichel, J. F. Healey, E. T. Parker, S. M. Donfield, J. Astermark, E. Berntorp, P. Lollar, D. Schwabe and C. Königs

    Version of Record online : 8 NOV 2016, DOI: 10.1111/hae.13105

  16. You have free access to this content
    The disappearing act of factor VIII

    Haemophilia

    Volume 16, Issue 102, May 2010, Pages: 6–15, P. J. LENTING, O. D. CHRISTOPHE and P. GUÉGUEN

    Version of Record online : 1 SEP 2008, DOI: 10.1111/j.1365-2516.2008.01864.x

  17. Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A

    Haemophilia

    Volume 18, Issue 2, March 2012, Pages: 248–254, S. DELIGNAT, Y. REPESSÉ, A. -M. NAVARRETE, Y. MESLIER, N. GUPTA, O. D. CHRISTOPHE, S. V. KAVERI and S. LACROIX-DESMAZES

    Version of Record online : 2 NOV 2011, DOI: 10.1111/j.1365-2516.2011.02679.x

  18. You have free access to this content
    Elevated factor VIII levels and risk of venous thrombosis

    British Journal of Haematology

    Volume 157, Issue 6, June 2012, Pages: 653–663, P. Vince Jenkins, Orla Rawley, Owen P. Smith and James S. O'Donnell

    Version of Record online : 25 APR 2012, DOI: 10.1111/j.1365-2141.2012.09134.x

  19. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency

    Haemophilia

    Volume 21, Issue 3, May 2015, Pages: e202–e209, O. Roualdes, C. Nougier, M. Fretigny, E. Talagrand, B. Durand, C. Negrier and C. Vinciguerra

    Version of Record online : 24 FEB 2015, DOI: 10.1111/hae.12651

  20. You have free access to this content
    The molecular mechanisms of immunomodulation and tolerance induction to factor VIII

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue 9, September 2009, Pages: 1446–1456, B. WATERS and D. LILLICRAP

    Version of Record online : 6 JUL 2009, DOI: 10.1111/j.1538-7836.2009.03538.x